Congratulations to Longwood Biopharmaceuticals for LW402 Accepted for Clinical Trial
Shanghai, September 26, 2020 – Congratulations to Longwood Biopharmaceuticals Co., Ltd for theirLW402 and tablet (CXHL2000303, CXHL2000304, CXHL2000305) have been accepted by the CDE (Center for Drug Evaluation), NMPA for clinical
September 26, 2020